Zixiang Cong
Overview
Explore the profile of Zixiang Cong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang T, Liang H, Han Y, Cong Z, Wang H, Wei P, et al.
Biochim Biophys Acta Mol Basis Dis
. 2025 Feb;
1871(4):167742.
PMID: 39986441
NDRG2, a recognized suppressor of tumor cell proliferation, displays downregulation in glioma, yet its specific regulatory mechanisms remain elusive. Our study validated the downregulation of NDRG2 in surgical glioma samples...
2.
He W, Cong Z, Niu C, Cheng F, Yi T, Yao Z, et al.
Sci Rep
. 2024 Aug;
14(1):18708.
PMID: 39134681
Clear cell renal cell carcinoma (ccRCC) is characterized by a high incidence and mortality rate. Despite advancements in therapeutic interventions, the prognosis for renal cancer patients remains suboptimal. Of late,...
3.
Geng Y, Dong Q, Cong Z, Zhu J, Li Z, Du C, et al.
J Neurol Surg B Skull Base
. 2024 Jul;
85(4):389-396.
PMID: 38966302
Biochemical remission rates of endoscopic endonasal transsphenoidal surgery (EETS) and its associated predictive factors were evaluated in patients with somatotrophin pituitary adenomas. The patients who underwent EETS in Jinling Hospital...
4.
Zheng B, Jiang X, Liu Y, Cheng F, Zhang Y, Niu C, et al.
Discov Oncol
. 2024 May;
15(1):156.
PMID: 38733531
Background: Clear cell renal cell carcinoma (ccRCC), the most common pathological subtype of kidney cancer, accounts for approximately 70% to 80% of all cases. Histone deacetylase 10 (HDAC10) belongs to...
5.
Qiao N, Gao W, Deng X, Xin T, Zhang G, Wu N, et al.
Int J Surg
. 2024 Mar;
110(7):4043-4052.
PMID: 38498406
Background: Surgical treatment of complex giant pituitary adenomas (GPAs) presents significant challenges. The efficacy and safety of combining transsphenoidal and transcranial approaches for these tumors remain controversial. In this largest...
6.
Tang T, Liang H, Wei W, Han Y, Cao L, Cong Z, et al.
Mol Biomed
. 2023 Nov;
4(1):42.
PMID: 37975957
Glioblastoma (GBM) is an aggressive intracranial tumour, and current chemotherapy regimens have limited efficacy. Aloperine (ALO), a natural alkaline compound, has shown potential as an antitumor agent. However, the effect...
7.
Zhang L, Hu Z, Bai W, Peng Y, Lin Y, Cong Z
iScience
. 2023 Nov;
26(11):108270.
PMID: 37965135
Fucoxanthin is the most abundant marine carotenoid extracted from seaweed. Our previous study has shown that fucoxanthin inhibited oxidative stress after traumatic brain injury (TBI). However, the effects of fucoxanthin...
8.
He W, Cong Z, Liu Y, Yao Z, Cheng F, Zhang Y, et al.
BMC Surg
. 2023 Aug;
23(1):252.
PMID: 37620830
Background: Radical nephrectomy with thrombectomy in patients with renal cell carcinoma (RCC) and level IV thrombus extending to the right atrium (RA) offers improved survival. However, this procedure is associated...
9.
Yuan F, Cai X, Wang Y, Du C, Cong Z, Zeng X, et al.
Int Immunopharmacol
. 2023 Aug;
124(Pt A):110784.
PMID: 37607464
Background: N6-methyladenosine (mA) RNA methylation and tumor immune microenvironment (IME) have an essential role in tumor development. However, their relationships in pituitary adenomas (PAs) remains unclear. Methods: PA datasets from...
10.
Ali A, Cai X, Zhu J, Geng Y, Du C, Yuan F, et al.
World Neurosurg
. 2023 Aug;
179:e135-e149.
PMID: 37586551
Background: Patients with pituitary adenomas (PAs) are at an increased risk preoperatively and postoperatively for hypopituitarism. Postoperative hypocortisolism is associated with increased mortality and morbidity as well as poor quality...